Anthony Oliva, Ph.D. joined Longeveron in 2015 as the company’s senior scientist. Earning his undergraduate degree in Biological Sciences from the University of Chicago and his Ph.D. in Neuroscience from Baylor College of Medicine, Oliva brings with him extensive experience in the fields of health science and education. Oliva did his post-doctoral research at the Oregon Health and Science University before relocating to Florida, where he has held a variety of professional appointments. His positions include assistant scientist with The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine; director, Viral Vector Core Facility, also at the Miller School of Medicine; and assistant professor, Herbert Wertheim College of Medicine, Florida International University. Oliva’s scientific findings have been published in numerous peer-reviewed journals.

Oliva was instrumental in Longeveron being awarded a $1 million grant from the Alzheimer’s Association, serving as the principal investigator for work with LMSCs to treat Neuroinflammation in Alzheimer’s disease. This grant allows for the examination for the safety and efficacy of LMSCs to treat patients with mild Alzheimer’s disease.